Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2019
Role of thyroid dysimmunity and thyroid hormones in endometriosis
Marine Peyneau, Niloufar Kavian, Sandrine Chouzenoux, et al.
The Journal of Clinical Investigation
|
December 21, 2013
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir
Romain Coriat, Jérôme Alexandre, Carole Nicco, et al.
International Journal of Molecular Sciences
|
November 11, 2022
A New Manganese Superoxide Dismutase Mimetic Improves Oxaliplatin-Induced Neuropathy and Global Tolerance in Mice
Caroline Prieux-Klotz, Henri Chédotal, Martha Zoumpoulaki, et al.
Journal of Medicinal Chemistry
|
September 15, 2010
Synthesis and selective anticancer activity of organochalcogen based redox catalysts
Mandy Doering, Lalla A Ba, Nils Lilienthal, et al.
Frontiers in Immunology
|
December 6, 2021
Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model
Martin Killian, Fabien Colaone, Philippe Haumont, et al.
Science Translational Medicine
|
September 3, 2010
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus
Pierre Duffau, Julien Seneschal, Carole Nicco, et al.
Molecular Cancer Therapeutics
|
January 11, 2017
Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications
Nathaniel Edward Bennett Saidu, Gaëlle Noé, Olivier Cerles, et al.
Plos One
|
March 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas
Guillaume Beinse, Pierre-Alexandre Just, Bastien Rance, et al.
Frontiers in Immunology
|
August 13, 2021
Corrigendum: The <i>Nrf2</i>-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma
Niloufar Kavian, Souad Mehlal, Mohamed Jeljeli, et al.
Arthritis Research & Therapy
|
January 6, 2022
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Cindy Orvain, Anne Cauvet, Alexis Prudent, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2019
Role of thyroid dysimmunity and thyroid hormones in endometriosis
Marine Peyneau, Niloufar Kavian, Sandrine Chouzenoux, et al.
The Journal of Clinical Investigation
|
December 21, 2013
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir
Romain Coriat, Jérôme Alexandre, Carole Nicco, et al.
International Journal of Molecular Sciences
|
November 11, 2022
A New Manganese Superoxide Dismutase Mimetic Improves Oxaliplatin-Induced Neuropathy and Global Tolerance in Mice
Caroline Prieux-Klotz, Henri Chédotal, Martha Zoumpoulaki, et al.
Journal of Medicinal Chemistry
|
September 15, 2010
Synthesis and selective anticancer activity of organochalcogen based redox catalysts
Mandy Doering, Lalla A Ba, Nils Lilienthal, et al.
Frontiers in Immunology
|
December 6, 2021
Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model
Martin Killian, Fabien Colaone, Philippe Haumont, et al.
Science Translational Medicine
|
September 3, 2010
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus
Pierre Duffau, Julien Seneschal, Carole Nicco, et al.
Molecular Cancer Therapeutics
|
January 11, 2017
Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications
Nathaniel Edward Bennett Saidu, Gaëlle Noé, Olivier Cerles, et al.
Plos One
|
March 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas
Guillaume Beinse, Pierre-Alexandre Just, Bastien Rance, et al.
Frontiers in Immunology
|
August 13, 2021
Corrigendum: The <i>Nrf2</i>-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma
Niloufar Kavian, Souad Mehlal, Mohamed Jeljeli, et al.
Arthritis Research & Therapy
|
January 6, 2022
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Cindy Orvain, Anne Cauvet, Alexis Prudent, et al.
Page
of 10